In treatment experiments using the orthotopic transplanted mouse model of CRC, the WEE1 inhibitor significantly reduced tumor volume, and immunostaining revealed the infiltration of CD8-positive T cells into the tumors in the treated group. The gene discussed is WEE1; the disease is neoplasm.